New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients
Oh Young Bang, Keun-Sik Hong, Ji Hoe Heo, Jaseong Koo, Sun U. Kwon, Kyung-Ho Yu, Hee-Joon Bae, Byung-Chul Lee, Byung-Woo Yoon, Jong S. Kim
J Stroke. 2014;16(2):73-80.   Published online 2014 May 30     DOI:
Citations to this article as recorded by Crossref logo
The risk and timing of acute ischemic stroke after electrical cardioversion for atrial fibrillation in Taiwan: A nationwide population-based cohort study
Chih-Kang Huang, Jen-Chun Wang, Chi-Hsiang Chung, Sy-Jou Chen, Wen-I Liao, Wu-Chien Chien
International Journal of Cardiology.2022; 351: 55.     CrossRef
Association of risk factors and bleeding complications in Asian patients taking edoxaban
Ok Sang Lee, Woorim Kim, Bo Min Jang, Kyung Hyun Min, Yoon Sook Cho, Myung Koo Lee, Kyung Eun Lee
British Journal of Clinical Pharmacology.2021; 87(4): 2121.     CrossRef
Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs
Chun-Li Wang, Victor Chien-Chia Wu, Kuo-Hsuan Chang, Hui-Tzu Tu, Chang-Fu Kuo, Yu-Tung Huang, Pao-Hsien Chu, Chi-Ching Kuo, Shang-Hung Chang
European Heart Journal - Cardiovascular Pharmacotherapy.2020; 6(3): 147.     CrossRef
A Review of the Medical Challenges of Using Direct Oral Anticoagulants in Real-World Practice
IlYoung Cho
Therapeutic Innovation & Regulatory Science.2020; 54(4): 793.     CrossRef
Intracerebral hemorrhage associated with warfarin versus non-vitamin K antagonist oral anticoagulants in Asian patients
Ho Geol Woo, Inyoung Chung, Dong Seok Gwak, Baik Kyun Kim, Ji Hoon Kang, Beom Joon Kim, Hee-Joon Bae, Moon-Ku Han
Journal of Clinical Neuroscience.2019; 61: 160.     CrossRef
Short‐Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?
Wern Yew Ding, Ahsan A. Khan, Dhiraj Gupta, Gregory Y. H. Lip
Journal of the American Heart Association.2019;[Epub]     CrossRef
Atrial Fibrillation Accompanying Mitral Stenosis
Bi Huang
Journal of the American College of Cardiology.2019; 73(25): 3361.     CrossRef
Implications of CHA2DS2-VASc Score in Stroke Patients with Atrial Fibrillation: An Analysis of 938 Korean Patients
Jaechun Hwang, Jong-Won Chung, Mi Ji Lee, Gyeong-Moon Kim, Chin-Sang Chung, Kwang Ho Lee, Oh Young Bang
European Neurology.2017; 77(5-6): 307.     CrossRef
Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation
Ki Hong Lee, Hyung Wook Park, Nuri Lee, Dae Young Hyun, Jumin Won, Sung Sik Oh, Hyuk Jin Park, Yongcheol Kim, Jae Yeong Cho, Min Chul Kim, Doo Sun Sim, Hyun Joo Yoon, Nam Sik Yoon, Kye Hun Kim, Young Joon Hong, Ju Han Kim, Youngkeun Ahn, Myung Ho Jeong, J
EP Europace.2017; 19(suppl_4): iv1.     CrossRef
Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
Oh Young Bang, Keun-Sik Hong, Ji Hoe Heo
Journal of Stroke.2016; 18(2): 169.     CrossRef
Traditional Risk Factors for Stroke in East Asia
Young Dae Kim, Yo Han Jung, Gustavo Saposnik
Journal of Stroke.2016; 18(3): 273.     CrossRef
Practical aspects of treatment with target specific anticoagulants: initiation, payment and current market, transitions, and venous thromboembolism treatment
Charles E. Mahan
Journal of Thrombosis and Thrombolysis.2015; 39(3): 295.     CrossRef
Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda
Chen-Huan Chen, Mien-Cheng Chen, Harry Gibbs, Sun U. Kwon, Sidney Lo, Young Keun On, Azhari Rosman, Nijasri C. Suwanwela, Ru San Tan, Louie S. Tirador, Andreas Zirlik
International Journal of Cardiology.2015; 191: 244.     CrossRef
Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai‐ VTE trial
M. Nakamura, Y. Q. Wang, C. Wang, D. Oh, W.‐H. Yin, T. Kimura, K. Miyazaki, K. Abe, M. Mercuri, L. H. Lee, A. Segers, H. Büller
Journal of Thrombosis and Haemostasis.2015; 13(9): 1606.     CrossRef
The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society
Byung Chun Jung, Nam Ho Kim, Gi Byung Nam, Hyung Wook Park, Young Keun On, Young Soo Lee, Hong Euy Lim, Boyoung Joung, Tae Joon Cha, Gyo Seung Hwang, Seil Oh, June Soo Kim
Korean Circulation Journal.2015; 45(1): 9.     CrossRef
Amiodarone Use Is Associated With Increased Risk of Stroke in Patients With Nonvalvular Atrial Fibrillation
Wei-Chun Chen, Wei-Cheng Chen, Chih-Yu Chen, Biing-Ru Wu, Wen-Chien Cheng, Kuo-Hung Lin, Te-Chun Hsia, Wei Chen, Chia-Hung Chen, Chih-Hsin Muo, Wei-Chih Liao, Chia-Hsiang Li
Medicine.2015; 94(19): e849.     CrossRef
Rationale and Design of Triple AXEL: Trial for Early Anticoagulation in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation
Keun-Sik Hong, Yun Jung Choi, Sun U. Kwon
International Journal of Stroke.2015; 10(1): 128.     CrossRef
Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants
Alexander Cohen, Sinnadurai Jeyaindran, Jae Yeol Kim, Kihyuk Park, Suree Sompradeekul, Karmel L. Tambunan, Huyen Tran, I-Chen Tsai, Christopher Ward, Raymond Wong
Thrombosis Research.2015; 136(2): 196.     CrossRef
Thromboembolic Risks That Require Consideration for Antithrombotic Therapy in Japanese Patients With Atrial Fibrillation
Hiroshi Tada
Circulation Journal.2014; 78(10): 2373.     CrossRef
The Primary Goal of Anticoagulation in Atrial Fibrillation to Prevent Stroke and Not to Offer the Apparently Cheapest Treatment
Hans-Christoph Diener
Journal of Stroke.2014; 16(2): 57.     CrossRef